Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ: ATRC )

38.47 +0.83 (+2.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 903,175
Open 37.98
Bid (Size) 36.15 (1)
Ask (Size) 39.90 (1)
Prev. Close 37.64
Today's Range 37.22 - 39.12
52wk Range 18.94 - 39.12
Shares Outstanding 45,882,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From AtriCure, Inc.
Via Business Wire

Performance

YTD
+26.55%
+26.55%
1 Month
+26.09%
+26.09%
3 Month
+34.79%
+34.79%
6 Month
+61.50%
+61.50%
1 Year
+12.22%
+12.22%

More News

Read More
Cracking The Code: Understanding Analyst Reviews For AtriCure
Via Benzinga
Navigating 6 Analyst Ratings For AtriCure
Via Benzinga
Analyst Ratings For AtriCure
Via Benzinga
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Stifel 2024 Healthcare Conference
From AtriCure, Inc.
Via Business Wire
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
AtriCure Reports Third Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the UBS Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
From AtriCure
Via Business Wire
AtriCure to Announce Third Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
AtriCure Receives CE-Mark for the EnCompass® Clamp
From AtriCure, Inc.
Via Business Wire
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
From AtriCure, Inc.
Via Business Wire
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
From AtriCure, Inc.
Via Business Wire
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
Via InvestorPlace
AtriCure Reports Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
From AtriCure, Inc.
Via Business Wire
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
From AtriCure, Inc.
Via Business Wire
AtriCure to Announce Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From AtriCure, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.